• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌演进与动力学。

Evolution and dynamics of pancreatic cancer progression.

机构信息

1] Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA [2] Division of Refractory Cancer Research, National Cancer Center Research Institute, Tokyo, Japan.

出版信息

Oncogene. 2013 Nov 7;32(45):5253-60. doi: 10.1038/onc.2013.29. Epub 2013 Feb 18.

DOI:10.1038/onc.2013.29
PMID:23416985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3823715/
Abstract

Efficient metastasis is believed as the result of multiple genetic, epigenetic and/or post-translational events in the lifetime of a carcinoma. At the genetic level, these events may be categorized into those that occur during carcinogenesis, and those that occur during subclonal evolution. This review summarizes current knowledge of the genetics of pancreatic cancer from its initiation within a normal cell until the time that is has disseminated to distant organs, many features of which can be extrapolated to other solid tumor types. The implications of these findings to personalize genome analyses of an individual patient's tumor are also discussed.

摘要

人们认为,有效的转移是癌在其一生中发生的多种遗传、表观遗传和/或翻译后事件的结果。在遗传水平上,这些事件可分为在癌变过程中发生的事件和在亚克隆进化过程中发生的事件。本综述总结了目前对胰腺癌遗传学的认识,从正常细胞内的起始到已经扩散到远处器官的过程,其中许多特征可以外推到其他实体肿瘤类型。还讨论了这些发现对个体患者肿瘤的个体化基因组分析的意义。

相似文献

1
Evolution and dynamics of pancreatic cancer progression.胰腺癌演进与动力学。
Oncogene. 2013 Nov 7;32(45):5253-60. doi: 10.1038/onc.2013.29. Epub 2013 Feb 18.
2
Translational research in pancreatic cancer: KRAS and beyond.胰腺癌的转化研究:KRAS及其他相关研究
Pancreas. 2014 Jan;43(1):150-2. doi: 10.1097/MPA.0b013e31829629f6.
3
Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.胰腺导管腺癌中 K-ras、p53、c-erbB-2 和 DPC4 的基因改变及其与患者生存的相关性。
Pancreas. 2013 Mar;42(2):216-22. doi: 10.1097/MPA.0b013e31825b6ab0.
4
Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.胰腺中p16的破坏和Kras的激活会增加体内导管腺癌的形成和转移。
Oncotarget. 2011 Nov;2(11):862-73. doi: 10.18632/oncotarget.357.
5
Clinical Effect of Driver Mutations of , and in Pancreatic Cancer: A Meta-Analysis.胰腺癌中 、 和 驱动基因突变的临床效应:一项荟萃分析。
Genet Test Mol Biomarkers. 2020 Dec;24(12):777-788. doi: 10.1089/gtmb.2020.0078.
6
Genetics and Biology of Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌的遗传学与生物学
Hematol Oncol Clin North Am. 2015 Aug;29(4):595-608. doi: 10.1016/j.hoc.2015.04.003. Epub 2015 Jun 10.
7
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.胰腺癌的遗传特征及其对潜在长期生存者识别的临床意义。
Clin Cancer Res. 2012 Nov 15;18(22):6339-47. doi: 10.1158/1078-0432.CCR-12-1215. Epub 2012 Sep 18.
8
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.胰腺腺鳞癌具有与胰腺导管腺癌相似的KRAS2、DPC4和TP53分子改变。
Mod Pathol. 2009 May;22(5):651-9. doi: 10.1038/modpathol.2009.15. Epub 2009 Mar 6.
9
Genetic and epigenetic alterations of familial pancreatic cancers.家族性胰腺癌的基因和表观遗传改变。
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3536-42. doi: 10.1158/1055-9965.EPI-08-0630.
10
Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.永存癌症转移的复杂性:通过快速尸检获得的致死性转移性胰腺癌的遗传特征
Cancer Biol Ther. 2005 May;4(5):548-54. doi: 10.4161/cbt.4.5.1663. Epub 2005 May 12.

引用本文的文献

1
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia.空间蛋白质组学和转录组学揭示胰腺上皮内瘤变中早期免疫细胞组织。
JCI Insight. 2025 Jun 26;10(15). doi: 10.1172/jci.insight.191595. eCollection 2025 Aug 8.
2
Advances in tumor subclone formation and mechanisms of growth and invasion.肿瘤亚克隆形成以及生长和侵袭机制的进展
J Transl Med. 2025 Apr 21;23(1):461. doi: 10.1186/s12967-025-06486-3.
3
Unlocking the Genetic Secrets of Pancreatic Cancer: Allelic Imbalances in Tumor Evolution.

本文引用的文献

1
Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.免疫组化检测到 3 个主要基因(CDKN2A/p16、TP53 和 SMAD4/DPC4)的表达水平强烈预测了可切除胰腺癌患者的生存情况。
Ann Surg. 2013 Aug;258(2):336-46. doi: 10.1097/SLA.0b013e3182827a65.
2
Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis.缺氧诱导因子介导的肿瘤-间质细胞相互作用促进血管生成、淋巴管生成和转移。
Oncogene. 2013 Aug 29;32(35):4057-63. doi: 10.1038/onc.2012.578. Epub 2012 Dec 10.
3
揭开胰腺癌的遗传奥秘:肿瘤进化中的等位基因失衡
Cancers (Basel). 2025 Apr 4;17(7):1226. doi: 10.3390/cancers17071226.
4
Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.利用微小RNA网络理解胰腺癌——文献综述
Biomedicines. 2024 Aug 1;12(8):1713. doi: 10.3390/biomedicines12081713.
5
Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma.胰腺炎和胰腺导管腺癌的诊断和预后标志物。
Int J Mol Sci. 2024 Jun 16;25(12):6619. doi: 10.3390/ijms25126619.
6
Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up.胰腺癌的分子病理学与蛋白质标志物:在分期、辅助治疗、微小残留病的确定及随访中的相关性
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):56-70. doi: 10.21037/hbsn-22-628. Epub 2023 Aug 14.
7
Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case-control study.弥漫性胰腺实质萎缩,一种预测胰腺导管腺癌发生的影像学表现:一项病例对照研究。
JGH Open. 2023 Jun 2;7(6):445-452. doi: 10.1002/jgh3.12930. eCollection 2023 Jun.
8
Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.循环游离核酸作为胰腺癌诊断和预后的生物标志物
Biomedicines. 2023 Apr 1;11(4):1069. doi: 10.3390/biomedicines11041069.
9
Pancreatic Juice Cytology Evaluations Using Synthetic Secretin and Serial Pancreatic Juice Aspiration Cytological Examination for the Diagnosis of Pancreatic Ductal Adenocarcinoma.使用合成促胰液素和系列胰液抽吸细胞学检查进行胰液细胞学评估以诊断胰腺导管腺癌
Diagnostics (Basel). 2023 Apr 25;13(9):1536. doi: 10.3390/diagnostics13091536.
10
Recent advances in targeted therapy for pancreatic adenocarcinoma.胰腺腺癌靶向治疗的最新进展
World J Gastrointest Oncol. 2023 Apr 15;15(4):571-595. doi: 10.4251/wjgo.v15.i4.571.
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.
结直肠癌依赖于基质细胞中 TGF-β 驱动的程序进行转移起始。
Cancer Cell. 2012 Nov 13;22(5):571-84. doi: 10.1016/j.ccr.2012.08.013.
4
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.胰腺癌基因组揭示了神经导向途径基因的异常。
Nature. 2012 Nov 15;491(7424):399-405. doi: 10.1038/nature11547. Epub 2012 Oct 24.
5
Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.缺氧诱导低侵袭性和高侵袭性胰腺肿瘤细胞发生 EMT,但只有具有癌症干细胞特征的细胞才获得显著的迁移能力。
PLoS One. 2012;7(9):e46391. doi: 10.1371/journal.pone.0046391. Epub 2012 Sep 26.
6
Keys to personalized care in pancreatic oncology.胰腺癌个性化治疗的关键。
J Clin Oncol. 2012 Nov 20;30(33):4049-50. doi: 10.1200/JCO.2012.45.1799. Epub 2012 Oct 8.
7
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.胰腺癌的遗传特征及其对潜在长期生存者识别的临床意义。
Clin Cancer Res. 2012 Nov 15;18(22):6339-47. doi: 10.1158/1078-0432.CCR-12-1215. Epub 2012 Sep 18.
8
Molecular pathways in pancreatic carcinogenesis.胰腺发生癌变过程中的分子通路。
J Surg Oncol. 2013 Jan;107(1):8-14. doi: 10.1002/jso.23213. Epub 2012 Jul 17.
9
Pancreatic surgery for adenocarcinoma.腺癌的胰腺切除术。
Curr Opin Gastroenterol. 2012 Sep;28(5):488-93. doi: 10.1097/MOG.0b013e3283567f2c.
10
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.结直肠癌中针对 EGFR 阻断的获得性耐药的分子进化。
Nature. 2012 Jun 28;486(7404):537-40. doi: 10.1038/nature11219.